Erik Gatenholm
Born 1989. CEO since 2016.
Education and work experience:
B.Sc. at Virginia Tech University and a M.Sc. in Innovation & Industrial Management from Gothenburg University. Erik has documented success in biotechnology entrepreneurship with more than 13 years of entrepreneurial experience. Honors include: Forbes 30 Under 30, MIT Review 35 Under 35, and Entrepreneur of the year 2020.
Other board assignments:
Board member of BICO Group AB and chairman of BICO International AB
Shareholding in BICO:
A-shares: 848,958, B-shares: 8,767,036. Ownership: 15%, voting right: 22.24%
Jacob Thordenberg
Chief Financial Officer
Born 1985, CFO since 2023.
Education:
M.Sc Corporate and financial management from Lund University, Sweden.
Work experience:
Over 10 years of financial experience, including Head of M&A at BICO, M&A Director at Telia Company and Deloitte Transaction Services.
Other board assignments:
None
Shareholding in BICO:
900 B shares. 12,000 options (LTIP 2021)
Dr. Héctor Martinez
EVP, CTO & Co-founder
Born 1985. CTO since 2016.
Education and work experience:
M.Sc. and PhD in Biomedical Engineering from Chalmers University of Technology. Hector has over 10 years of experience in developing and commercializing cutting-edge converging technologies that enable our customers to create, understand and master biology.
Other board assignments:
Board member of BICO International AB
Shareholding in BICO:
A-shares: 567,709, B-shares: 5,751,695. Ownership: 9.73%, voting right: 14.62%
Marius Balger
Chief Operating Officer
Born 1968, COO since March 2023
Education:
Master of Science in General Mechanical Engineering (Diplom-Ingenieur) Technical University Darmstadt – Hesse, Germany.
Work experience:
27 years of general business management experience and 21 Years in Life Science and IVD. Including cross-functional responsibilities ranging from operations, through building and leading sales and distribution networks, product development, lean manufacturing to after-sale service. Key leadership functions filled in the past such as: General Manager and VP Asia Pacific at MAN AG, CEO of a midsize CDMO and Senior Vice President Partnering Business at Tecan AG.
Other board assignments:
Currently none, Advisory function at Kilobaser GmbH and AmplifiDx, Inc.
Shareholding in BICO:
–
Lotta Bus
Born 1970. General Counsel since 2020.
Education and work experience:
LL.M. University of Lund & Maastricht. Over 20 years of experience as an attorney working for the law firms Vinge, MAQS and Magnusson including 14 years of experience of management as partner and five years as CEO.
Other board assignments:
Board member of Sincrly AB and BICO International AB.
Shareholding in BICO:
B-shares: 7,000
Artur Aira
Born 1967. Head of Corporate Development & M&A since March 2023.
Education and work experience:
Medtech Eng., and MBA, Chalmers. More than 25 years’ experience in Life Science (biotech, Pharma, Diagnostics). Former CEO of Organon, bioMerieux Nordics, Ad-dtech Life Lifescience, Addlife dvlp, COO and Exec VP Addlife and Abigo Medical AB.
Other board assignments:
Has Board member experience of more than 35 companies. Board member of Integrum and Predicare. Board member of CELLINK 2017-2020.
Shareholding in BICO:
B-shares: 80,000
Options: 40,000
